Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Tax Provisions of $3871.0 for Q1 2026, down 83.35% sequentially from $23245.0 in Q4 2025, and down 31.73% YoY from $5670.0 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Tax Provisions for 17 years, with the latest figure at $3871.0 in Q1 2026.
- Quarterly Tax Provisions fell 31.73% year-over-year to $3871.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38457.0 (up 235.22% YoY) and the FY2025 annual result came in at $40256.0, up 277.58% from the prior year.
- Tax Provisions declined to $3871.0 in Q1 2026 per CPIX's latest filing, from $23245.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $48150.0 in Q4 2022 and troughed at -$56996.0 in Q4 2024.
- A 5-year average of $8004.5 and a median of $6937.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions surged 284.71% in 2022, then tumbled 328.39% in 2024.
- Over 5 years, Tax Provisions stood at $48150.0 in 2022, then sank by 48.17% to $24956.0 in 2023, then slumped by 328.39% to -$56996.0 in 2024, then jumped by 140.78% to $23245.0 in 2025, then plunged by 83.35% to $3871.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $3871.0, $23245.0, and $5670.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.16 Mn | 110.30 Mn | - | 3,870.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,870.00 |
| Mar 31, 2026 | 3,871.00 |
| Dec 31, 2025 | 23,245.00 |
| Sep 30, 2025 | 5,670.00 |
| Jun 30, 2025 | 5,671.00 |
| Mar 31, 2025 | 5,670.00 |
| Dec 31, 2024 | -56,996.00 |
| Sep 30, 2024 | 11,442.00 |
| Jun 30, 2024 | 11,443.00 |
| Mar 31, 2024 | 11,442.00 |
| Dec 31, 2023 | 24,956.00 |
| Sep 30, 2023 | 6,938.00 |
| Jun 30, 2023 | 6,937.00 |
| Mar 31, 2023 | 6,938.00 |
| Dec 31, 2022 | 48,150.00 |
| Sep 30, 2022 | 6,900.00 |
| Jun 30, 2022 | 6,900.00 |
| Mar 31, 2022 | 6,900.00 |
| Dec 31, 2021 | 12,516.00 |
| Sep 30, 2021 | 7,458.00 |